Hiroshi Hori
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis 4
-
- Diabetes Management and Research 6
- Surgery top 10%
- Pancreatic function and diabetes 8
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid 4
-
- Diabetes and associated disorders 5
-
- Nitric Oxide and Endothelin Effects 3
-
- Kidney Stones and Urolithiasis Treatments 3
-
- Hallucinations in medical conditions 3
- Co-authors
- Kazutomo InoueYuanjun GuNicholas T. ZervasYasuhiko TabataNatsuki NagataF. LarinR. J. WurtmanMichael H. Lavyne
- Journals
- Nature (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)
- Partner nations
- JapanUnited StatesBritish Virgin Islands
In The Last Decade
Hiroshi Hori
67 papers receiving 922 citations
Peers
Comparison fields: 5 of 119
- Pharmacology 150
- Endocrinology, Diabetes and Metabolism 144
- Surgery 296
- Neurology 51
- Nephrology 42
Countries citing papers authored by Hiroshi Hori
This map shows the geographic impact of Hiroshi Hori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Hori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Hori more than expected).
Fields of papers citing papers by Hiroshi Hori
This network shows the impact of papers produced by Hiroshi Hori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Hori. The network helps show where Hiroshi Hori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroshi Hori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 0 | |
| 6 | 2017 | 9 | |
| 7 | 2013 | 20 | |
| 8 | 2009 | 21 | |
| 9 | 2006 | 1 | |
| 10 | 2003 | 51 | |
| 11 | 2002 | 65 | |
| 12 | 2002 | 15 | |
| 13 | 2001 | 13 | |
| 14 | 2000 | 36 | |
| 15 | 1999 | 27 | |
| 16 | 1998 | 32 | |
| 17 | 1996 | 30 | |
| 18 | 1995 | 3 | |
| 19 | 1993 | 6 | |
| 20 | 1989 | 6 |
About Hiroshi Hori
Hiroshi Hori is a scholar working on Nephrology, Pharmacology and Developmental Neuroscience, having authored 77 papers that have together received 976 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (8 papers), Diabetes Management and Research (6 papers), Diabetes and associated disorders (5 papers), Gout, Hyperuricemia, Uric Acid (4 papers), Microbial Natural Products and Biosynthesis (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Kidney Stones and Urolithiasis Treatments (3 papers) and Hallucinations in medical conditions (3 papers). The work is most often cited by research in Pharmacology (150 citations), Endocrinology, Diabetes and Metabolism (144 citations) and Surgery (296 citations). Hiroshi Hori has collaborated with scholars based in Japan, United States and British Virgin Islands. Frequent co-authors include Kazutomo Inoue, Yuanjun Gu, Nicholas T. Zervas, Yasuhiko Tabata, Natsuki Nagata, F. Larin, R. J. Wurtman, Michael H. Lavyne, Toru Shimizu and Akira Satake. Their work appears in journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.